Mitsukuni Yoshida, MD, PhD, a current resident physician in the department’s Academic Scholar Advancement Program (ASAP), has been selected for the prestigious 2024 Emerging-Generation (E-Gen) Awards by the American Society for Clinical Investigation (ASCI).
The ASCI, a nonprofit medical honor society, supports the scientific efforts, educational needs, and clinical aspirations of physician-scientists with the goal of improving the health of all people. Composed of more than 3,000 members across various medical specialties, the Society is committed to advancing research that enhances our understanding of diseases and improves treatment.
The ASCI E-Gen Awards, with only 33 recipients selected from a competitive pool of 91 nominations, recognize post-MD, pre-faculty appointment physician-scientists engaged in immersive research. Throughout the next two years, Yoshida will participate in leadership development workshops, panel discussions, and other scientific and career-oriented networking and mentorship opportunities in the ASCI community. This includes attending the AAP/ASCI/APSA Joint Meeting in Chicago, IL, on April 5-7, 2024.
“Dr. Yoshida’s selection for the ASCI Emerging-Generation Award reflects not only his exceptional research contributions but also his commitment to pushing the boundaries of medical science,” said Head of the Department of Anesthesiology, Michael S. Avidan, MBBCh, FCA SA. “We are proud to have him as part of our team, and this recognition is well-deserved.”
Yoshida graduated from Washington University School of Medicine in 2021, where he earned his MD and a PhD in Neuroscience. As an ASAP Scholar, he has spent the past three years as a resident physician and will begin his clinical fellowship in Pain Medicine in February 2024. During this fellowship, he will be able to devote more time to his research, which focuses on modulating the immune system to alleviate chronic pain while exploring intersections of aging, metabolism, and neuroscience. Previously, he conducted groundbreaking research on cancer metastasis and systemic NAD+ biosynthesis, earning prestigious awards like the Dr. Philip Needleman Pharmacology Prize. Utilizing cutting-edge technologies, Dr. Yoshida aims to decipher molecular mechanisms underlying aging and chronic pain to enhance elderly patient care.
For more information about the ASCI E-Gen Awards and to see the full list of awardees, please visit ASCI’s website.